oral glutathione bioavailability human randomized trial supplementation improves fat graft survival by inhibiting ferroptosis via the SLC7A11/GPX4 axis | Stem Cell Research & Therapy Enhancing the Oral Bioavailability of
Description
Allow 48-72 hours between sessions targeting the same muscle groups

By converting lipid hydroperoxides into non-toxic lipid alcohols, the selenoprotein glutathione peroxidase 4 (GPX4) in three isoforms with differing subcellular locations prevents ferroptosis with assistance from the ferroptosis suppressor protein 1 (FSP1), tocopherol, reduced coenzyme Q, and 7dehydrocholesterol

Curr Alzheimer Res, 12:377-383

As with all medications, there is the possibility of unknown risks and late side-effects

These experiments show that extracellular aSYN aggregates can be absorbed, disseminate, and cause LP despite their limitations [28]
